Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: amyloid beta

May 13, 2024 CD as API / Pharma applications

The Single Toxin Origin of Alzheimer’s Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention

New data suggest that the aggregation of misfolded native proteins initiates and drives the pathogenic cascade that leads to Alzheimer’s

Continue reading

December 18, 2023 CD as API / Pharma applications / Uncategorized

HPBCD was tested as a possible therapeutic agent in Amyotrophic Lateral Sclerosis (ALS) model

Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), is a rare and terminal neurodegenerative disease that results

Continue reading

November 10, 2022 CD as API / Food / Pharma applications

Beer to prevent Alzheimer Disease

Beer is one of the oldest and most popular beverages in the world. Its bitter taste comes from the hops

Continue reading

March 12, 2022 Life sciences

KLVFF oligopeptide-decorated amphiphilic cyclodextrin nanomagnets for selective amyloid beta recognition and fishing for selective amyloid beta recognition and fishing

Recognition and capture of amyloid beta is a challenging task for the early diagnosis of neurodegenerative disorders, such as Alzheimer’s

Continue reading

September 3, 2020 Drug delivery / Pharma applications

Delivering Crocetin across the Blood-Brain Barrier by Using γ-Cyclodextrin to Treat Alzheimer’s Disease

Scientific report has published a paper on γ-cyclodextrin-enabled crocetin formulation which can deliver crocetin into the brain. [1] Crocetin (CRT)

Continue reading

January 15, 2019 Drug delivery

Antibiotics degradation products against Alzheimer’s disease

A recent paper in Cell Reports published an interesting finding: polymeric degradation products (compound X and Z, respectively) of antibiotics

Continue reading

November 6, 2018 CD as API / Pharma applications

HPBCD treatment of Alzheimer’s disease

CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with

Continue reading

Recent Posts

  • Surface-Engineered Amino-Graphene Oxide Aerogel Functionalized with Cyclodextrin for Desulfurization and Denitrogenation in Oil Refining
  • Cyclodextrin and KR12-Lipopeptide Interactions
  • Comparative study of thiolated and alkenylated functionalized β-CDs as highly mucopenetrating and mucoadhesive drug delivery systems.
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • Arthur Lütringhaus, Godfather of catenanes was born 120 years ago

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (63)
  • CD as API (339)
  • CD derivatives (395)
  • Cosmetics and toilettry (49)
  • Diagnosis (11)
  • Drug delivery (774)
  • E-ducation (63)
  • Environmental (129)
  • Events (232)
  • Food (217)
  • Gene delivery (19)
  • Household products (1)
  • Household products (4)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (390)
  • Other industrial use (104)
  • Pharma applications (1,156)
  • Supramolecular systems (40)
  • Uncategorized (140)

Top Posts

  • Recent papers on Cyclodextrins in Nature
  • HPαCD Therapy: A Breakthrough for Krabbe Disease Treatment
  • Nanoparticles with Green Tea for Inhibition of β-Amyloid Fibrillation
  • Cyclodextrin and KR12-Lipopeptide Interactions
  • The Genetic Basis, Lung Involvement, and Therapeutic Options in Niemann–Pick Disease: A Comprehensive Review
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Nobel Prize winner in 2016 for Chemistry, Sir James Fraser Stoddart at ICS 20
  • End of year statistics, 2025
  • Cyclodextrin Phosphates
  • Lanosterol eye drops for cataract treatment

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,792 other subscribers
 

Loading Comments...